Market Research Logo

Medherant Ltd - Product Pipeline Analysis, 2018 Update

Summary

Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormone therapy, and others. Its TEPI patch technology enables the production of patches with effective doses of active ingredients with enhanced long-term drug delivery. Medherant provides high drug loading patches for ibuprofen transdermal and methyl salicylate delivery. The company works in partnership with other companies such as AdhexPharma and Bostik to manufacture TEPI Patch products. It is a spinoff of the University of Warwick. Medherant is headquartered in Coventry, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Medherant Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Medherant Ltd Company Overview
Medherant Ltd Company Snapshot 4
Medherant Ltd Pipeline Products and Ongoing Clinical Trials Overview
Medherant Ltd – Pipeline Analysis Overview 6
Medherant Ltd - Key Facts 6
Medherant Ltd - Major Products and Services 7
Medherant Ltd Pipeline Products by Development Stage 8
Medherant Ltd Pipeline Products Overview 9
Ibuprofen TEPI Patch 9
Ibuprofen TEPI Patch Product Overview 9
Lidocaine TEPI Patch 10
Lidocaine TEPI Patch Product Overview 10
Methyl Salicylate TEPI Patch 11
Methyl Salicylate TEPI Patch Product Overview 11
Medherant Ltd - Key Competitors 12
Medherant Ltd - Key Employees 13
Medherant Ltd - Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Medherant Ltd, Recent Developments 15
Mar 07, 2018: Medherant expands team with appointment of David Davies as Head of Development 15
Nov 17, 2017: Medherant wins Excellence in Science & Technology Award 15
Oct 18, 2017: Warwick graduate invents revolutionary device for testing drugs 16
Sep 26, 2017: Medherant Signs Agreement with Leading Japanese Transdermal Patch Company for Evaluation of Its TEPI Patch Drug Delivery System 17
Jun 26, 2017: Medherant appoints new COO and CFO 17
Jun 26, 2017: Medherant expands management team with appointment of Sally Waterman, COO and Angus Hone, CFO 18
Jun 06, 2017: Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products Based on its Revolutionary TEPI Patch 18
May 08, 2017: Medherant Appoints Laboratoires Plasto Santé as Transdermal Drug Delivery Patch Manufacturer 19
Feb 06, 2017: Medherant Announces Appointment of New Chair 19
Feb 22, 2016: Medherant's First Ibuprofen Patch – TEPI Patch Technology 20
Appendix 21
Methodology 21
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Tables
Medherant Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Medherant Ltd Pipeline Products by Equipment Type 5
Medherant Ltd Pipeline Products by Indication 5
Medherant Ltd, Key Facts 6
Medherant Ltd, Major Products and Services 7
Medherant Ltd Number of Pipeline Products by Development Stage 8
Medherant Ltd Pipeline Products Summary by Development Stage 8
Ibuprofen TEPI Patch - Product Status 9
Ibuprofen TEPI Patch - Product Description 9
Lidocaine TEPI Patch - Product Status 10
Lidocaine TEPI Patch - Product Description 10
Methyl Salicylate TEPI Patch - Product Status 11
Methyl Salicylate TEPI Patch - Product Description 11
Medherant Ltd, Key Employees 13
Glossary 23
List of Figures
Medherant Ltd Pipeline Products by Equipment Type 5
Medherant Ltd Pipeline Products by Development Stage 8

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report